Markets:

Overview

News

Currencies

International

Treasuries

Korro Bio, Inc. - Common Stock (NQ:KRRO)

10.29 -0.44 (-4.10%)

Streaming Delayed Price Updated: 12:28 PM EST, Jan 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Korro Bio, Inc. - Common Stock

< Previous 1 2 Next >

The Great Rotation: Small-Caps Seize the Spotlight as Mega-Cap Fatigue Sets In

December 22, 2025

As 2025 draws to a close, the financial landscape has undergone a seismic shift that few predicted at the start of the year. For the first time in over half a decade, the dominant narrative of "Big...

Via MarketMinute

Topics Economy

The Great Rotation: Small-Caps Break Out as Russell 2000 Hits Record Highs in Late 2025

December 18, 2025

NEW YORK — In a dramatic shift that has recalibrated the pulse of Wall Street, the Russell 2000 index has finally staged its long-awaited breakout, signaling a definitive end to the years-long...

Via MarketMinute

Topics Artificial Intelligence ETFs Economy

Korro Bio Stock Crashes Over 75% After-Hours On Drug Failure, Downgrades And Layoffs — Yet Retail Flags ‘Buy-The-Fear’ Setup ↗

November 12, 2025

Via Stocktwits

Topics Workforce

On Monday, there are stocks with unusual volume. Let's take a look. ↗

November 17, 2025

The trading volume of these stocks is deviating from the norm in today's session.

Via Chartmill

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

November 13, 2025

Via Benzinga

Keep an eye on the top gainers and losers in Thursday's session. ↗

November 13, 2025

Intrigued by the market activity one hour before the close of the markets on Thursday? Uncover the key winners and losers of today's session in our insightful analysis.

Via Chartmill

Korro Bio Early Trial Results Fall Short; Stock Hits New Low ↗

November 13, 2025

Korro Bio shares drop after KRRO-110 trial in AATD misses protein goals; company cuts 34% of staff and shifts focus to liver-targeted programs.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

November 13, 2025

Via Benzinga

Dow Dips Over 400 Points; JD.com Posts Upbeat Q3 Results ↗

November 13, 2025

Via Benzinga

Topics Stocks

Which stocks are gapping on Thursday? ↗

November 13, 2025

The market is buzzing with gapping stocks on Thursday. Let's uncover which stocks are experiencing notable gaps during today's session.

Via Chartmill

Nasdaq Down Over 150 Points; Disney Shares Fall After Q4 Results ↗

November 13, 2025

Via Benzinga

Korro Bio Plummets To A Record Low On A Big Setback In RNA-Editing ↗

November 13, 2025

Korro Bio stock plummeted Thursday after its RNA-editing drug failed in patients with a rare lung and liver disease.

Via Investor's Business Daily

Stay updated with the stocks that are on the move in today's pre-market session. ↗

November 13, 2025

The US market session of Thursday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.

Via Chartmill

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

November 13, 2025

Via Benzinga

Why Cisco Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket ↗

November 13, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

October 20, 2025

Via Benzinga

3 Biotech Stocks Showing Strength With Big Spikes In Momentum Scores ↗

September 12, 2025

A handful of biotech stocks are showing renewed strength, with big spikes in their Benzinga Edge Ranking's Momentum scores.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

September 03, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

May 27, 2025

Via Benzinga

Uber To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Thursday ↗

May 08, 2025

Via Benzinga

This UroGen Pharma Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday ↗

April 16, 2025

Via Benzinga

CAMP4 Appoints John Maraganore and Rachel Meyers as Strategic Advisors

December 10, 2024

Industry veterans John Maraganore, Ph.D., and Rachel Meyers, Ph.D., to provide strategic guidance on the company’s RNA Actuating platform to develop a new class of RNA medicines that upregulate protein...

From CAMP4 Therapeutics

Via GlobeNewswire

This TechnipFMC Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗

November 18, 2024

Via Benzinga

Korro Bio Is Lagging Wave Life Sciences In RNA Editing. Why It Could Ultimately Lead The Space. ↗

October 21, 2024

Korro Bio is lagging Wave Life Sciences. But an analyst says it could ultimately be the leader.

Via Investor's Business Daily

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

October 16, 2024

Via Benzinga

United Airlines Posts Upbeat Earnings, Joins Morgan Stanley, U.S. Bancorp And Other Big Stocks Moving Higher On Wednesday ↗

October 16, 2024

Via Benzinga

3 Stocks That Could Rise on European Bank Interest Rate Cuts

September 22, 2024

The European Central Bank cut interest rates for the second time in about three months prior the FOMC's interest rate announcement, European stocks may benefit.

Via MarketBeat

Topics Economy

Novo Nordisk Just Took a $530 Million Step Onto Moderna's Turf. Here's What It Means for Both Stocks ↗

September 19, 2024

This strategic play will take time to pay off, but it could keep growth going.

Via The Motley Fool

Novo Nordisk Inks $600M Genetic Medicines Pact With Canadian Firm To Target Cardiometabolic Indications ↗

September 18, 2024

Wednesday, Canada-based NanoVation Therapeutics announced a multi-year partnership with Novo Nordisk A/S (NYSE:NVO) to advance the ...

Via Benzinga

Gold Edges Lower; US Homebuilder Sentiment Rises For September ↗

September 17, 2024

Via Benzinga

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.